Dr Isaac Goncalves
Clinical (Senior Lecturer)
Baker Department of Cardiometabolic Health
18 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Myeloid/lymphoid neoplasms with eosinophilia and ZMYM2::FLT3 fusion: clinical, pathological and molecular clues to a cryptic diagnosis
DOI: 10.1016/j.pathol.2026.02.0092025
Journal article
Therapy-Related Myeloid Neoplasms After [177Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series
DOI: 10.2967/jnumed.124.2686402025
Journal article
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study
DOI: 10.1002/ajh.275392024
Journal article
Updated treatment options for immune thrombocytopenia
DOI: 10.1111/imj.162462024
Journal article
Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes
DOI: 10.1016/j.rpth.2024.1023422023
Conference Proceedings
Initial Report of Part B Phase 1/2 Efficacy and Safety Results for Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed Immune Thrombocytopenia
DOI: 10.1182/blood-2023-1778082022
Journal article
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia
DOI: 10.1056/NEJMoa2110297
RECENT SCHOLARLY WORKS
2022
Journal article
Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand
DOI: 10.5694/mja2.512842021
Journal article
Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo
DOI: 10.1097/MBC.00000000000010082019
Conference Proceedings
Prospective, Comprehensive Cardiac Assessment in Patients Receiving BTK Inhibitor Therapy
DOI: 10.1182/blood-2019-129808